Product Name :
PSMA-617
CAS NO. :
1702967-37-0
Formula :
C49H71N9O16
Molecular Weight::
1042.14
Target:
Drug-Linker Conjugates for ADC
Serial Number:
Short serial number :
Purity:
95%
Description :
Vipivotide tetraxetan (PSMA-617) is a high potent prostate-specific membrane antigen (PSMA) inhibitor, with a Ki of 0.37 nM. Vipivotide tetraxetan (PSMA-617) is designed consisting of three components: the pharmacophore Glutamate-urea-Lysine, the chelator DOTA able to complex both 68Ga or 177Lu, and a linker connecting these two entities. Glutamate-urea-Lysine is the selective pharmacophore to bind to prostate specific membrane antigen.
References:
[1]. Benešová M, et al. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer. J Nucl Med. 2015 Jun;56(6):914-20.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
VEGF Receptor 1 Antibody
RAB8A Antibody
VCAM1 Antibody: VCAM1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 81 kDa, targeting to VCAM1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.